
Archean Chemical Q1 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- Bromine sales volume is expected to increase from current ~4,273 tons in Q1 FY24 to around 25,000 to 28,000 tons by FY26 with ~90% capacity utilization.
- Bromine derivatives capacity of 28,000 tons expected to have ~24,000-25,000 tons volume by FY26. Bromine consumed in derivatives expected to be 13,000-16,000 tons.
- Salt segment maintains strong volume run rate of about 1 million tons per quarter; demand robust due to chlorine usage expansion.
- SOP (Sulfate of Potash) volumes expected to grow with domestic market traction and stabilization anticipated in current financial year.
- Downstream bromine derivative projects (Phase 1 and 2 including flame retardants) expected full utilization by FY25/FY26, with flame retardants commissioning targeted in Q1 FY25.
- Export market demand for bromine picking up with recovering global customers; domestic demand remains firm despite price pressures.
- Overall revenue growth supported by bromine, derivatives, salt, and SOP segments as capacity expansion and market recovery progresses.
See what Archean Chemical management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Archean Chemical management said on order book — free account, 30 seconds.
Capex plans
Yes- Archean Chemical Industries is executing a capex for bromine derivative projects in two phases: Phase 1 includes brominated clear brine fluids, PTA synthesis catalysts, and allied products; Phase 2 focuses on flame retardants.
- The flame retardant plant commissioning is targeted for Q1 FY25, with possible early commissioning in FY24, but it's subject to technical product evaluations and customer approvals.
- The bromine capacity is being expanded by 32,000 tons, and bromine derivatives capacity by 28,000 tons, with full utilization expected around FY26.
- R&D setup is operational with a current 4-member team, planned to grow to 10 members by FY25 focusing on industry applications and product trials.
- Industrial salt washeries expansion with two additional conveyor lines is targeted for commissioning around March 2024, pending weather conditions.
- Overall, capex and strategic investments are aimed at strengthening integration and product portfolio to enhance competitiveness and market share.
Track Archean Chemical — get its next earnings analysis in your feed
How does Archean Chemical rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Archean Chemical rank in Chemicals & Petrochemicals?
Compare Archean Chemical against every Chemicals & Petrochemicals company (Q1 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Archean Chemical's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Seya Industries (Q2 FY27)
Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's
- DCM Shriram Fine Chemicals (Q2 FY27)
9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri
- Dhariwalcorp (Q2 FY27)
For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…
- Agastya Energy (Q2 FY27)
For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…